Literature DB >> 19222606

High frequency of common DNA copy number abnormalities detected by bacterial artificial chromosome array comparative genomic hybridization in 24 breast cancer cell lines.

Soichiro Saito1, Keiko Morita, Takashi Hirano.   

Abstract

Breast cancer is a widespread disease in Japan and across the world. Breast cancer cells, as well as most other types of cancer cells, have diverse chromosomal aberrations. Clarifying the character of these chromosomal aberrations should contribute to the development of more suitable therapies, along with the predictions of metastasis and prognosis. Twenty-four breast cancer cell lines were analyzed by bacterial artificial chromosome (BAC) array comparative genomic hybridization (CGH). The array slide contained duplicate spots of 4030 BAC clone DNAs covering the entire human genome with 1 Mbp resolution. In all 24 breast cancer cell lines, frequent and significant amplifications as well as deletions were detected by BAC array CGH. Common DNA copy number gains, detected in 60% (above 15 cell lines) of the 24 breast cancer cell lines were found in 76 BAC clones, located at 1q, 5p, 8q, 9p, 16p, 17q, and 20q. Moreover, common DNA copy number loss was detected in 136 BAC clones, located at 1q, 2q, 3p, 4p, 6q, 8p, 9p, 11p, 13q, 17p, 18q, 19p, Xp, and Xq. The DNA copy number abnormalities found included abnormality of the well-known oncogene cMYC (8q24.21); however, most of them were not reported to relate to breast cancer. BAC array CGH has great potential to detect DNA copy number abnormalities, and has revealed that breast cancer cell lines have substantial heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222606     DOI: 10.1111/j.1749-0774.2008.00061.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  34 in total

1.  BAC array CGH reveals genomic aberrations in idiopathic mental retardation.

Authors:  Noriko Miyake; Osamu Shimokawa; Naoki Harada; Nadia Sosonkina; Aiko Okubo; Hiroki Kawara; Nobuhiko Okamoto; Kenji Kurosawa; Hiroshi Kawame; Mie Iwakoshi; Tomoki Kosho; Yoshimitsu Fukushima; Yoshio Makita; Yuji Yokoyama; Takanori Yamagata; Mitsuhiro Kato; Yoko Hiraki; Masayo Nomura; Ko-ichiro Yoshiura; Tatsuya Kishino; Tohru Ohta; Takeshi Mizuguchi; Norio Niikawa; Naomichi Matsumoto
Journal:  Am J Med Genet A       Date:  2006-02-01       Impact factor: 2.802

2.  Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.

Authors:  S Solinas-Toldo; S Lampel; S Stilgenbauer; J Nickolenko; A Benner; H Döhner; T Cremer; P Lichter
Journal:  Genes Chromosomes Cancer       Date:  1997-12       Impact factor: 5.006

3.  A bacterial artificial chromosome library for sequencing the complete human genome.

Authors:  K Osoegawa; A G Mammoser; C Wu; E Frengen; C Zeng; J J Catanese; P J de Jong
Journal:  Genome Res       Date:  2001-03       Impact factor: 9.043

4.  The PVT gene frequently amplifies with MYC in tumor cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 6.  The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.

Authors:  Jeffrey S Ross; Jonathan A Fletcher; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; W Fraser Symmans; Lajos Pusztai; Kenneth J Bloom
Journal:  Oncologist       Date:  2003

7.  Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review.

Authors:  Masataka Yoshimoto; Keiichiro Tada; Haruko Hori; Akira Morota; Masahiko Tanabe; Seiichiro Nishimura; Kaoru Takahashi; Masujiro Makita; Takuji Iwase; Fujio Kasumi; Syunji Takahashi; Yoshinori Ito; Masahiro Oguchi; Takashi Yamashita; Futoshi Akiyama; Goi Sakamoto
Journal:  Jpn J Clin Oncol       Date:  2004-08       Impact factor: 3.019

8.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis.

Authors:  S Hu; M Zhang; Z Lv; J Bi; Y Dong; J Wen
Journal:  Neoplasma       Date:  2007       Impact factor: 2.575

10.  High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.

Authors:  Tara L Naylor; Joel Greshock; Yan Wang; Theresa Colligon; Q C Yu; Virginia Clemmer; Tal Z Zaks; Barbara L Weber
Journal:  Breast Cancer Res       Date:  2005-11-24       Impact factor: 6.466

View more
  9 in total

1.  Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.

Authors:  Hannah Carter; Rachel Marty; Matan Hofree; Andrew M Gross; James Jensen; Kathleen M Fisch; Xingyu Wu; Christopher DeBoever; Eric L Van Nostrand; Yan Song; Emily Wheeler; Jason F Kreisberg; Scott M Lippman; Gene W Yeo; J Silvio Gutkind; Trey Ideker
Journal:  Cancer Discov       Date:  2017-02-10       Impact factor: 39.397

2.  Use of BAC array CGH for evaluation of chromosomal stability of clinically used human mesenchymal stem cells and of cancer cell lines.

Authors:  Soichiro Saito; Keiko Morita; Arihiro Kohara; Tohru Masui; Mari Sasao; Hajime Ohgushi; Takashi Hirano
Journal:  Hum Cell       Date:  2010-12-31       Impact factor: 4.174

3.  CKS1BP7, a Pseudogene of CKS1B, is Co-Amplified with IGF1R in Breast Cancers.

Authors:  Yansong Liu; Wei Wang; Yan Li; Feifei Sun; Jiaxiang Lin; Li Li
Journal:  Pathol Oncol Res       Date:  2017-04-24       Impact factor: 3.201

4.  MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region.

Authors:  A-rum Yoon; Ran Gao; Zeenia Kaul; Il-Kyu Choi; Jihoon Ryu; Jane R Noble; Yoshio Kato; Soichiro Saito; Takashi Hirano; Tetsuro Ishii; Roger R Reddel; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  Nucleic Acids Res       Date:  2011-06-30       Impact factor: 16.971

5.  Inference of tumor phylogenies from genomic assays on heterogeneous samples.

Authors:  Ayshwarya Subramanian; Stanley Shackney; Russell Schwartz
Journal:  J Biomed Biotechnol       Date:  2012-05-13

6.  A feasible diagnostic approach for the translocation carrier from the indication of products of conception.

Authors:  Ye-Qing Qian; Xiao-Ying Fu; Xiao-Qing Wang; Yu-Qin Luo; Min Chen; Kai Yan; Yan-Mei Yang; Bei Liu; Li-Ya Wang; Ying-Zhi Huang; Hong-Ge Li; Hang-Yi Pan; Fan Jin; Min-Yue Dong
Journal:  Mol Cytogenet       Date:  2018-01-30       Impact factor: 2.009

7.  Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues.

Authors:  Katumi Tsuji; Shigeto Kawauchi; Soichiro Saito; Tomoko Furuya; Kenzo Ikemoto; Motonao Nakao; Shigeru Yamamoto; Masaaki Oka; Takashi Hirano; Kohsuke Sasaki
Journal:  BMC Cancer       Date:  2010-01-14       Impact factor: 4.430

8.  Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.

Authors:  Charlotte L T Jørgensen; Bent Ejlertsen; Karsten D Bjerre; Eva Balslev; Dorte L Nielsen; Kirsten V Nielsen
Journal:  BMC Cancer       Date:  2013-11-12       Impact factor: 4.430

9.  TiHo-0906: a new feline mammary cancer cell line with molecular, morphological, and immunocytological characteristics of epithelial to mesenchymal transition.

Authors:  José Luis Granados-Soler; Johannes Junginger; Marion Hewicker-Trautwein; Kirsten Bornemann-Kolatzki; Julia Beck; Bertram Brenig; Daniela Betz; Jan Torben Schille; Hugo Murua Escobar; Ingo Nolte
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.